Highlights

  • Regis Healthcare (ASX:REG) reported FY26 Revenue growth of 16% to $1.35 billion and underlying EBITDA growth of 10% to $138 million.
  • Net Operating Cash Flow increased to $336.3 million, supported by $250.5 million of net RAD cash inflows.
  • The company increased its fully franked FY26 Dividend by 13% to 18.40 cents per share.
  • Investors are focused on RAD repricing benefits, acquisitions, development pipeline and long-term Margin improvement.

Regis Healthcare (ASX:REG) delivered a stronger FY26 result, supported by higher occupancy, acquisitions, improved accommodation pricing and significant growth in refundable accommodation deposit (RAD) inflows. The company continues to reposition aged care as a scalable healthcare infrastructure opportunity, using stronger cash generation to fund expansion. However, margins remain under pressure from workforce costs and government funding settings, making operational execution a key focus.

Cashflows reshape the aged care growth story

Regis Healthcare's FY26 result highlighted the increasing importance of accommodation-related cash flows.

The company benefited from higher room pricing, strong occupancy and growing RAD balances, which have strengthened its financial position.

The aged care operator is using this improved cash generation to support:

  • acquisitions;
  • greenfield developments;
  • refurbishment programs;
  • shareholder returns.

The company's strategy is built around expanding its portfolio of quality aged care homes while improving financial flexibility.

However, the challenge remains converting higher revenue and cash inflows into stronger operating margins.

The Key Development

The major development from FY26 was the continued growth of RAD balances and the impact of room repricing.

Following aged care accommodation reforms, Regis increased pricing across its portfolio.

During July and August 2026, the company repriced approximately 70% of rooms, increasing average advertised room prices by 10%.

As existing residents transition and new residents enter care, Regis expects progressive repricing of paid-up RADs to generate more than $500 million of net operating cash inflows over time.

The company also expects recurring RAD retention Earnings to exceed $50 million annually once fully phased in.

Under the new Aged Care Act, providers can retain 2% per year of RADs from new residents entering care from 1 November 2025, capped over five years.

The maximum RAD room price without additional approval increased to $750,000 from January 2025 and was indexed to $789,686 from July 2026.

These reforms are expected to provide additional support for sector funding over time.

Financial Performance

Regis delivered improved financial performance across key measures.

For FY26:

  • Revenue from services increased 16.3% to $1,350.6 million.
  • Underlying EBITDA increased 9.7% to $138.0 million.
  • Underlying NPAT increased 4.2% to $55.6 million.
  • Statutory NPAT increased 13.8% to $55.7 million.

Net operating cash flow increased 9.8% to $336.3 million.

This included net RAD cash inflows of $250.5 million, up from $195.4 million in FY25.

The Balance Sheet remained supportive, with net cash of $173.8 million at 30 June 2026.

Operational performance also improved.

Mature homes average occupancy increased to 96.0% from 95.6%.

Occupied bed days increased 8% to 2.85 million.

However, profitability faced cost pressure.

Staff expenses increased 18.7% to $1,055.1 million due to:

  • higher wage costs following Fair Work Commission decisions;
  • annual wage increases;
  • enterprise agreement adjustments;
  • additional staffing requirements to meet care-minute targets.

Underlying EBITDA margin declined to 10.2% from 10.8%.

Management noted that lower-than-expected AN-ACC price indexation did not fully offset higher care delivery costs.

Growth Through Acquisitions and Development

Regis continued expanding its aged care portfolio during FY26.

The company completed:

Rockpool acquisition
Regis acquired four residential aged care homes with approximately 600 beds in South-East Queensland for $138.4 million.

Since acquisition, the Business generated $64.7 million in net RAD cash inflows, reducing the net Investment requirement.

OC Health acquisition
Regis acquired two Victorian aged care homes with approximately 230 beds for $44.7 million.

The Acquisition provides exposure to the Greater Geelong region and future RAD pricing opportunities.

Regis also progressed a greenfield development pipeline of approximately 1,300 beds across nine sites.

The 123-bed Toowong Facility in Brisbane is nearing completion, with opening expected during summer 2026/27.

Construction at Carlingford is also underway.

What Management Is Saying

Managing director and CEO Andrew Kinkade highlighted strong occupancy, RAD inflows and portfolio expansion as key drivers of FY26 performance.

Management believes Regis is well positioned to benefit from:

  • favourable demographic trends;
  • increasing Demand for quality aged care accommodation;
  • improved workforce availability;
  • funding reforms under the new Aged Care Act.

The company intends to continue expanding beyond 10,000 beds through acquisitions and greenfield developments.

Management also emphasised continued investment in technology, care quality and operational efficiency.

Why Investors Are Reacting

Investor interest is centred on Regis' improving cash generation profile.

The combination of high occupancy, higher accommodation pricing and growing RAD balances has changed the market view of aged care operators.

RAD inflows provide a funding source that can support growth without relying entirely on external capital.

The company’s acquisition strategy is also becoming increasingly important, with newly acquired homes providing opportunities for occupancy improvements and pricing optimisation.

However, investors remain focused on whether stronger cash generation can translate into improved margins.

The decline in EBITDA margin highlights the pressure created by wages, care requirements and government funding settings.

What Could Drive the Stock Next

Several factors could influence Regis' next phase of growth.

Key drivers include:

  • further RAD repricing benefits;
  • successful integration of acquisitions;
  • completion of greenfield developments;
  • improved AN-ACC funding outcomes;
  • stronger operating margins.

The company expects its development pipeline and acquisition strategy to expand its portfolio beyond 10,000 beds.

The opening of Toowong and progress across other development sites will be important milestones.

A stronger connection between cash generation and earnings growth would further support the investment case.

Risks to Watch

The main risk is margin pressure.

Higher wages, workforce requirements and care costs could continue affecting profitability if funding adjustments do not fully compensate for cost increases.

Regulatory changes remain another consideration.

The aged care sector continues to evolve, and future funding settings could affect operator returns.

Execution risks also remain.

Regis must successfully integrate acquisitions while delivering new developments on time and within budget.

Occupancy is already high, meaning future growth relies increasingly on expansion rather than filling existing capacity.

Interest rates, construction costs and labour availability could also affect development returns.

Investor Takeaway

Regis Healthcare (ASX:REG) delivered a strong FY26 result, supported by higher revenue, improved cash generation, acquisitions and growing RAD inflows.

The company's strategy is increasingly focused on using accommodation cash flows to fund long-term expansion.

The return of stronger Shareholder distributions, including a 13% increase in annual dividends to 18.40 cents per share, highlights confidence in the financial position.

However, the next challenge is converting these advantages into sustainable earnings growth.

Investors should monitor RAD repricing progress, margin trends, funding reforms, acquisition integration and delivery of the 1,300-bed development pipeline.

Regis has strengthened its position as a major aged care operator, but long-term value creation will depend on balancing growth investment with operational profitability.